Minimally invasive esophagectomy
Minimally invasive esophagectomy is a medical procedure with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Exploring the Optimal Timing of Minimally Invasive Surgery for Esophageal Squamous Cell Carcinoma
RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).
The Comparison of Single and Multi-incision MIE for Esophageal Cancer
Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC
Morbidity in Open Versus Minimally Invasive Esophagectomy
Clinical Trials (6)
Exploring the Optimal Timing of Minimally Invasive Surgery for Esophageal Squamous Cell Carcinoma
RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).
The Comparison of Single and Multi-incision MIE for Esophageal Cancer
Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC
Morbidity in Open Versus Minimally Invasive Esophagectomy
Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6